Reference
Khouri J, et al. Daratumumab is safe and highly effective in al amyloidosis. Blood 130 (Suppl. 1): 1819, Dec 2017. Available from: URL: http://www.bloodjournal.org/content/130/Suppl_1/1819 [abstract] - USA
Rights and permissions
About this article
Cite this article
Daratumumab. Reactions Weekly 1695, 143 (2018). https://doi.org/10.1007/s40278-018-43970-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43970-8